Eupraxia Pharmaceuticals Inc.

C$9.71As of Sun 8 Nov 2026, 12:00 UTC
TSX:EPRXHealthcare
Country Canada
PE (Fwd) •••
TSR 6Y CAGR 11.63%
Div yield —
ROE (66.70%)
Biotechnology
Beta (5Y) 1.33
PE TTM —
TSR TTM 21.38%
Mkt cap C$640.0M
ROIC (46.80%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
12.91%
(43.45%)
Hold 6|6|7|11|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.13
0.14
0.15
0.15
15.16%
25.92%
18.45%
15.11%
Revenue$M
36.90
37.13
39.30
39.04
13.22%
9.33%
15.70%
8.61%
Peers (US$453.0M)
Cap (US$)
PE
654.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.288
0.070
0.060
EBIT/Intx
1.120
0.440
0.425
Own earn%
6.19
(92.05)
(79.05)
Sh yield%
23.77
26.53
25.05
Owners
Insiders/Inst%
8.11
62.79
Short interest%
1.56
SBC / revenue%
3.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
19–25
$1 testx
0.0
Incr. ROIC%
−1